Search Results - "Burger, Charles D"

Incremental Burden of Pulmonary Hypertension Among Patients With Interstitial Lung Disease in the Real‐World Setting.

Authors: Burger, Charles D. Wu, Jasmanda O'Brien, Gerald et al.

Source: Pulmonary Circulation. Oct2025, Vol. 15 Issue 4, p1-12. 12p.

Impact of selexipag maintenance dose on persistence, adherence, and hospitalization in US patients with pulmonary arterial hypertension.

Authors: Burger, Charles D. Tang, Wenze Tsang, Yuen et al.

Source: Pulmonary Circulation. Jul2024, Vol. 14 Issue 3, p1-12. 12p.

Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry.

Authors: DuBrock, Hilary M. Burger, Charles D. Bartolome, Sonja D. et al.

Source: Pulmonary Circulation. Oct2022, Vol. 12 Issue 4, p1-2. 2p.

Pulmonary Hypertension in COPD: A Review and Consideration of the Role of Arterial Vasodilators.

Authors: Burger, Charles D.¹ (AUTHOR)

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease. Apr2009, Vol. 6 Issue 2, p137-144. 8p. 1 Diagram, 2 Charts.

Guest Editors' Memo.

Authors: DuBrock, Hilary Burger, Charles D.

Source: Advances in Pulmonary Hypertension. 2023, Vol. 22 Issue 2, p86-86. 1p.

Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.

Authors: Preston, Ioana R. Burger, Charles D. Bartolome, Sonja et al.

Source: Journal of Heart & Lung Transplantation. May2020, Vol. 39 Issue 5, p464-472. 9p.

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™in patients with pulmonary arterial hypertension.

Authors: Spikes, Leslie A. Bajwa, Abubakr A. Burger, Charles D. et al.

Source: Pulmonary Circulation. Apr2022, Vol. 12 Issue 2, p1-14. 14p.

Real‐World Comparison of Patients With PH‐ILD Initiating Inhaled Treprostinil Versus Patients Who Remain Untreated.

Authors: Cassady, Steven J. Ramani, Gautam V. Wu, Benjamin et al.

Source: Pulmonary Circulation. Oct2025, Vol. 15 Issue 4, p1-9. 9p.

Characterization of First-Time Hospitalizations in Patients With Newly Diagnosed Pulmonary Arterial Hypertension in the REVEAL Registry.

Authors: Burger, Charles D. Long, Pamela K. Shah, Monarch R. et al.

Source: CHEST. Nov2014, Vol. 146 Issue 5, p1263-1273. 11p.

Comparison of Body Habitus in Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management With Normative Values From the National Health and Nutrition Examination Survey.

Authors: Burger, Charles D. Foreman, Aimee J. Miller, Dave P. et al.

Source: Mayo Clinic Proceedings. Feb2011, Vol. 86 Issue 2, p105-112. 8p.

OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH GROUP 3 PULMONARY HYPERTENSION.

Authors: IDIL SECKIN, ZEYNEP BURGER, CHARLES D FESTIC, EMIR

Source: CHEST. 2023 Supplement, Vol. 164 Issue 4, pA5959-A5959. 1p.

OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH GROUP 2 PULMONARY HYPERTENSION.

Authors: IDIL SECKIN, ZEYNEP BURGER, CHARLES D FESTIC, EMIR

Source: CHEST. 2023 Supplement, Vol. 164 Issue 4, pA5900-A5900. 1p.

Editor's and Guest Editor's Memo.

Authors: Burger, Charles D. Schilz, Robert

Source: Advances in Pulmonary Hypertension. 2017, Vol. 16 Issue 1, p2-2. 1p.

Guest Editor's Memo.

Authors: Burger, Charles D. Schilz, Robert

Source: Advances in Pulmonary Hypertension. 2017, Vol. 15 Issue 4, p178-178. 1p.

Editor's Memo.

Authors: Burger, Charles D.¹

Source: Advances in Pulmonary Hypertension. 2017, Vol. 15 Issue 4, p178-178. 1p.

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Authors: Burger CD Burger, Charles D

Source: New England Journal of Medicine. 7/21/2011, Vol. 365 Issue 3, p271-272. 3p.

Low‑dose sirolimus in retroperitoneal lymphangioleiomyomas.

Authors: Ussavarungsi, Kamonpun Laroia, Archana T. Burger, Charles D.

Source: Lung India. Jul/Aug2019, Vol. 36 Issue 4, p349-352. 4p.

GUEST EDITOR'S MEMO.

Authors: Burger, Charles D. Forfia, Paul R.

Source: Advances in Pulmonary Hypertension. Summer2013, Vol. 12 Issue 2, p50-50. 2/3p.

LONG-TERM OUTCOMES AND DOSING IN THE BREEZE STUDY OPTIONAL EXTENSION PHASE.

Authors: SPIKES, LESLIE A BAJWA, ABUBAKR A BURGER, CHARLES D et al.

Source: CHEST. 2024 Supplement, Vol. 166 Issue 4, pA6061-A6063. 3p.

Prevalence of metabolic syndrome in patients with pulmonary hypertension.

Authors: Ussavarungsi, Kamonpun Thomas, Colleen S. Burger, Charles D.

Source: Clinical Respiratory Journal. Nov2017, Vol. 11 Issue 6, p721-726. 6p.